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Natural CD4
 
 
 
CD25
 
 
 
 regulatory T (CD4
 
 
 
CD25
 
 
 
 T reg) cells play a key role in the 
immunoregulation of autoimmunity. However, little is known about the interactions 
between CD4
 
 
 
CD25
 
 
 
 T reg cells and autoreactive T cells. This is due, in part, to the 
difficulty of using cell surface markers to identify CD4
 
 
 
CD25
 
 
 
 T reg cells accurately. Using 
a novel real-time PCR assay, mRNA copy number of FoxP3, TGF
 
 
 
1, and interleukin (IL)-10 
was measured in single cells to characterize and quantify CD4
 
 
 
CD25
 
 
 
 T reg cells in the 
nonobese diabetic (NOD) mouse, a murine model for type 1 diabetes (T1D). The suppressor 
function of CD4
 
 
 
CD25
 
 
 
CD62L
 
hi
 
 T cells, mediated by TGF
 
 
 
, declined in an age-dependent 
manner. This loss of function coincided with a temporal decrease in the percentage of FoxP3 
and TGF
 
 
 
1 coexpressing T cells within pancreatic lymph node and islet infiltrating 
CD4
 
 
 
CD25
 
 
 
CD62L
 
hi
 
 T cells, and was detected in female NOD mice but not in NOD male 
mice, or NOR or C57BL/6 female mice. These results demonstrate that the majority of 
FoxP3-positive CD4
 
 
 
CD25
 
 
 
 T reg cells in NOD mice express TGF
 
 
 
1 but not IL-10, and that 
a defect in the maintenance and/or expansion of this pool of immunoregulatory effectors is 
associated with the progression of T1D.
 
T1D is an autoimmune disease that is charac-
terized by the selective destruction of the insu-
lin-producing 
 
 
 
 cells which reside in the islets
of Langerhans (1, 2). Studies in the NOD
mouse, a spontaneous model of T1D, have
demonstrated that CD4
 
 
 
 and CD8
 
 
 
 T cells
are the primary mediators of 
 
 
 
 cell destruction
(1, 2). The critical events that contribute to
the breakdown of self-tolerance to 
 
 
 
 cells are
not well-understood, although defects in cen-
tral and peripheral tolerance have been impli-
cated in the development and differentiation
of pathogenic T effector cells (3–7).
The progression of T1D in NOD mice is
marked by two general “checkpoints” (8). The
first checkpoint is associated with infiltration
of the islets by macrophages, DCs, and B and
T cells. This insulitis begins at 
 
 
 
3 wk of age
and is well-established in 8–10-wk-old NOD
mice. Despite extensive insulitis, 
 
 
 
 cell de-
struction is limited and NOD mice remain di-
abetes-free during this period. The second
checkpoint corresponds with a shift from “be-
nign” to “aggressive” insulitis that begins at
 
 
 
12 wks of age. At this time, 
 
 
 
 cells are de-
stroyed efficiently to promote overt diabetes.
Typically, by 30 wk of age, 
 
 
 
80% and 
 
 
 
20%
of NOD female and male mice, respectively,
have developed diabetes. How the progression
from nondestructive to destructive insulitis is
regulated, or why the disparity in overt diabetes
exists between NOD female and male mice,
are not clear. However, interrelated events, in-
cluding islet recruitment of high avidity/affinity
 
 
 
 cell–specific T cells that exhibit a type 1
phenotype (9) and failing peripheral immuno-
regulatory mechanisms, are believed to con-
tribute (5–7).
Aberrant immunoregulation in NOD mice
initially was viewed in the context of a func-
tional imbalance between types 1 and 2 T
cells. Various studies have demonstrated that
induction of type 2 effectors, which are char-
acterized by the secretion of IL-4 and IL-10,
effectively prevents and/or suppresses the dia-
betogenic response in NOD mice (5, 10–12).
However, it is now apparent that immunoreg-
ulation of autoreactive T cells in general is
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highly complex and likely involves a heterogeneous group of
immunoregulatory T (and non–T) cell effectors. Indeed, in-
duction of type 1 regulatory T (T reg) cells, IL-10–only–
producing CD4
 
 
 
 T cells, and TGF
 
 
 
1-secreting Th3 cells
have been reported to prevent tissue-specific autoimmunity
(13–15).
Another subset of immunoregulatory effectors consists of
a naturally occurring population of CD4
 
 
 
CD25
 
 
 
 T reg
cells. CD4
 
 
 
CD25
 
 
 
 T reg cells upon TCR-mediated stimu-
lation are characterized by a potent in vitro and in vivo ca-
pacity to suppress proliferation and effector function of
CD4
 
 
 
 and CD8
 
 
 
 T cells, in addition to modulating the an-
tigen-presenting function of DCs (6, 16–19). Typically ac-
counting for 5–10% of murine peripheral CD4
 
 
 
 T cells,
CD4
 
 
 
CD25
 
 
 
 T reg cells play key roles in modulating im-
mune responses in a variety of models (6, 16–19). For exam-
ple, a reduced number of CD4
 
 
 
CD25
 
 
 
 T reg cells was asso-
ciated with exacerbation of T1D in NOD mice which
lacked CD80/CD86 or CD28 expression (6).
Current in vivo and in vitro studies strongly support the
view that CD4
 
 
 
CD25
 
 
 
 T reg cells represent a unique lin-
eage of immunoregulatory cells. However, accurate identifi-
cation, characterization, and quantification of CD4
 
 
 
CD25
 
 
 
T reg cells have been problematic. The IL-2R
 
 
 
 chain
(CD25) has been used widely for the identification and isola-
tion of CD4
 
 
 
CD25
 
 
 
 T reg cells, yet this marker also is ex-
pressed by activated CD4
 
 
 
 Th and memory T cells. Other
cell surface markers that are used to define CD4
 
 
 
CD25
 
 
 
 T
reg cells, including CD62L, cytotoxic T lymphocyte–associ-
ated antigen 4 (CTLA-4), glucocorticoid-induced TNF re-
ceptor gene (GITR), CD45RB, and CD103, also are shared
by “conventional” CD4
 
 
 
 Th cells (20). Recently, reports
demonstrated that the transcription factor, FoxP3, is ex-
pressed specifically by CD4
 
 
 
CD25
 
 
 
 T reg cells (21–23).
Furthermore, the Rudensky and Sakaguchi groups demon-
strated that FoxP3 is a master regulator of CD4
 
 
 
CD25
 
 
 
 T
reg cells differentiation. Transfer of FoxP3 cDNA into naive
CD4
 
 
 
 Th cells was sufficient to induce differentiation that
phenotypically and functionally resembled CD4
 
 
 
CD25
 
 
 
 T
reg cells (21, 23). The precise mode of suppression by
CD4
 
 
 
CD25
 
 
 
 T reg cells is not clear, but includes direct
cell–cell contact and/or production of inhibitory cytokines,
such as TGF
 
 
 
1 and IL-10 (24–26). Cell surface and secreted
TGF
 
 
 
1 have been associated with cell–cell contact depen-
dent and independent mechanisms of CD4
 
 
 
CD25
 
 
 
 T reg
cell–mediated suppression (24, 25). These different mecha-
nisms of suppression may reflect distinct subsets of CD4
 
 
 
CD25
 
 
 
 T reg cells and/or other types of immunoregulatory
effector cells.
With this in mind, we established an assay that was based
on real-time PCR to quantitate and characterize accurately
FoxP3 expressing CD4
 
 
 
CD25
 
 
 
 T reg cells at the single cell
level. This assay was used to test the hypothesis that progres-
sion of T1D in NOD mice is due to defects in CD4
 
 
 
CD25
 
 
 
T reg cell numbers and/or effector function. Evidence is
provided that demonstrates that the progression of benign to
aggressive insulitis corresponds with a temporal decrease in
peripheral tolerance as measured by reduced frequencies of
FoxP3 and TGF
 
 
 
1 coexpressing CD4
 
 
 
CD25
 
 
 
 T reg cells
residing in the PLNs and islets of NOD female mice.
 
RESULTS
The suppressor function of CD4
 
 
 
CD25
 
 
 
 T reg cells decreases 
in an age-dependent manner
 
Studies have suggested that defects in CD4
 
 
 
CD25
 
 
 
 T reg
cell function may contribute to the progression of 
 
 
 
 cell au-
toimmunity in NOD mice (6, 7). Accordingly, the suppres-
sor function of CD4
 
 
 
CD25
 
 
 
 T cells that were prepared
from PLNs of 4-, 8-, and 16-wk-old NOD female mice—
representing different stages of 
 
 
 
 cell autoimmunity—was
investigated in vitro. PLNs are reported to be a key site for
activation and tolerance induction of 
 
 
 
 cell specific T cells
Figure 1. PLN CD4 CD25  T reg cells suppressor function declines 
in an age-dependent manner. (A) Sorted PLN CD4 CD25  T cells from 
NOD female mice varying in age were tested at the indicated cell numbers 
to suppress proliferation determined via 3H-thymidine uptake of stimulated 
105 CD4 CD25  T cells that were isolated from 8-wk-old NOD female 
mice. Data are an average of two experiments performed in triplicate. 
Standard deviation of any given data point   10%. [3H]thymidine uptake 
of stimulated CD4 CD25  T cells alone   8192   874 cpm. *P   0.02, 
16 wk versus 8 or 4 wk (Student’s t test). (B) Groups of four NOD.scid female 
mice received 5   106 CD4  BDC2.5 T cells alone or in combination with 
5   105 sorted PLN CD4 CD25  T cells ( 98% purity) from NOD female 
mice at the indicated ages. *P   0.01, 4 wk or 8 wk vs. BDC2.5 alone (Kaplan 
Meier Log Rank test).JEM VOL. 201, April 18, 2005 1335
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(27). PLN CD4 CD25  T cells that were isolated from 4-
and 8-wk-old NOD female mice inhibited proliferation of
CD4 CD25- T cells similarly in cultures that were stimu-
lated with anti-CD3 mAb and irradiated syngeneic spleno-
cytes depleted of T cells (Fig. 1 A). In contrast, a significant
decrease in the suppressor function of PLN CD4 CD25  T
cells that were isolated from 16-wk-old mice versus 4- and
8-wk-old NOD mice was observed at limiting cell numbers
(P   0.02) (Fig. 1 A).
Next, an in vivo model was used to test CD4 CD25  T
cell suppressor function. CD4 CD25  T cells (5   105)
were cotransferred with BDC2.5 CD4 CD25- T cells (5  
106) into NOD.scid mice, and the development of diabetes
was monitored. NOD BDC2.5 mice are transgenic for the
diabetogenic BDC2.5 clonotypic TCR, and upon adoptive
transfer into NOD.scid mice cause a rapid onset of disease
(28). Coadoptive transfer of PLN CD4 CD25  T cells that
were isolated from 16-wk-old NOD female mice had no
significant effect on the time of diabetes onset relative to re-
cipients of CD4 CD25  BDC2.5 T cells alone (Fig. 1 B).
However, a significant delay in diabetes onset, beginning at
day 15 after transfer, was detected in NOD.scid recipients
that were coinjected with PLN CD4 CD25  T cells that
were prepared from 8 wk-old NOD female mice (P   
0.007). The development of diabetes was delayed further in
NOD.scid mice that received PLN CD4 CD25  T cells that
were isolated from 4-wk-old versus 8 wk-old NOD female
mice (P   0.009) (Fig. 1 B).
To determine the phenotype and effector function of
CD4 CD25  T reg cells more accurately, the in vitro sup-
pressor capacity of varying numbers of PLN CD62Lhi and
CD62Llo T cells was examined. The cell surface profile of
CD62Lhi versus CD62Llo is used commonly to discriminate
between CD4 CD25  T reg cells and activated CD4  Th
cells, respectively (29, 30). Similar to that observed in the
coadoptive transfer experiments (Fig. 1 B), PLN CD62Lhi T
Figure 2. The efficacy of in vitro suppression by PLN CD62Lhi T cells 
declines with age. Sorted CD62Lhi (A) or CD62Llo (B) T cells from the PLN 
of NOD female mice at different ages were tested at the indicated numbers 
to suppress proliferation of CD4 CD25  T cells as in Fig. 1 legend. Data are 
an average of two experiments performed in triplicate. Standard deviation 
of any given data point   13% (A) or   8%. (B) [3H]thymidine uptake 
of CD4 CD25  T cells alone is 8856 843 cpm. *P   0.01, 16 wk versus 8 
wk or 4 wk; @P   0.01, 4 wk versus 8 wk;  P   0.03, 16 wk versus 8 wk or 
4 wk; #P   0.02, 4 wk versus 8 wk (Student’s t test).
Figure 3. The percentage of CD62Lhi cells in the PLNs of NOD 
mice remains constant during disease progression. PLNs that were 
harvested from NOD female mice at indicated ages were analyzed by four-
color flow cytometry for CD3, CD4, CD25, and CD62L expression. CD4 CD25  
T cells were gated for lymphocytes based on forward and side scatter, and 
CD3 expression. CD62L expression was gated on forward scatter; side 
scatter; and CD3, CD4, and CD25 expression (box). Data are representative 
of five separate experiments.THE ROLE OF CD4 CD25  T REG CELLS IN AUTOIMMUNE DIABETES | Pop et al. 1336
cells that were prepared from 4-wk-old NOD female mice
proved to be the most effective at suppressing CD4 CD25 
T cell proliferation (Fig. 2 A). An intermediate level of sup-
pression was detected for CD62Lhi T cells that were isolated
from 8-wk-old NOD female mice, whereas CD62Lhi T cells
that were prepared from 16-wk-old NOD female mice were
the least effective (Fig. 2 A). The suppressor activity of
PLN CD62Llo T cells, albeit markedly reduced relative to
CD62Lhi T cells, exhibited a similar age-dependent decline
(Fig. 2 B). These results demonstrate that the capacity to me-
diate suppression by PLN CD4 CD25  T cells, specifically
CD62Lhi T cells, declines in a temporal manner.
An increase in PLN CD62Lhi T cells is detected as   cell 
autoimmunity progresses
Quantitative and/or qualitative changes may account for the
temporal decrease in CD4 CD25  T reg cell function that
was detected. To distinguish between these possibilities, the
number and frequency of PLN CD62Lhi T cells were deter-
mined in prediabetic and diabetic NOD female mice. Nota-
bly, the number of CD62Lhi T cells in the PLNs of predia-
betic NOD female mice increased with age (Table I). An
approximate threefold increase in the number of CD62Lhi T
cells was detected in the PLNs of 16-wk-old (147   10) ver-
sus 4-wk-old (54   5) NOD female mice (P   10 4; Table
I). In parallel, the number of CD62Llo T cells also increased
with age, so that the overall percentage of CD62Lhi T cells
was maintained during the progression of preclinical   cell
autoimmunity (Fig. 3, Table I). In the PLNs of recent onset
diabetic NOD female mice, no significant change in the
number of CD62Lhi T cells was detected relative to 16-wk-
old mice, although the percentage of these T cells was re-
duced as a result of increased numbers of CD62Llo T cells
(Fig. 3, Table I). Finally, within the pool of PLN CD62Lhi T
cells from prediabetic or diabetic NOD female mice, no sig-
nificant difference was detected in the number or percentage
of T cells which expressed additional markers that were asso-
ciated with CD4 CD25  T reg cells, including CTLA-4,
GITR, CD69, CD103, and CD45RB (data not shown).
Together, these results indicate that the number of CD62Lhi
T cells in the PLNs of NOD female mice increases as   cell
autoimmunity progresses, and is maintained at the onset
of diabetes. Furthermore, an increase in the number of
CD62Llo T cells, and not a decrease in CD62Lhi T cells in
the PLN, correlates with the onset of diabetes.
A temporal decrease in FoxP3-expressing CD62Lhi T cells 
is unique to NOD mouse PLNs
The above findings indicated that despite an increase in the
number of CD62Lhi T cells up to 16 wk in age, suppressor
activity diminished within this pool. To further define the
defect in PLN CD4 CD25  T reg cells, mRNA expression
of FoxP3, TGF , and IL-10 were measured. For this pur-
pose, a real-time PCR assay was used to measure RNA tran-
script copy number in individual cells. Single CD62Lhi,
CD62Llo, and CD4 CD25  T cells were sorted from PLNs
that were prepared from pools of four prediabetic or recent
diabetic NOD female mice; FoxP3, TGF 1, and IL-10 tran-
script number were measured in the same individual cells.
Consistent with previous findings, only a small percentage
( 3%) of CD4 CD25  T cells expressed low copies
( 100–200) of FoxP3 mRNA per cell (Fig . 4 A and B; refs.
Table I. Average absolute number of CD4 , CD4 CD25 , CD25 CD62Lhi, and CD25 CD62Llo per 10,000 lymphocytes within 
the PLNs of NOD female and NOD male mice
Average absolute number
4 wk 8 wk 16 wk Diabetic
(%) (%) (%) (%)
NOD female PLN
CD4  1,959   118 2,895   117 4,945   425 7,070   448
CD25  156   20 291   57 495   71 654   42
CD25 CD62Lhi 54   5 (34.6)a 101   8 (34.7) 147   10 (30.0) 140   10 (21.4)
FoxP3 CD25 CD62Lhi 37b 50 43 35
CD25 CD62Llo 107   8 (68.6)a 192   11(66.0) 340   13 (68.7) 510   20 (78.0)
FoxP3 CD25 CD62Llo 37b 44 61 63
NOD male PLN
CD4  2,789   109 ND 5,432   306 ND
CD25  251   23 ND 456   37 ND
CD25 CD62Lhi 79   7 (31.5)a ND 150   13 (32.9) ND
FoxP3 CD25 CD62Lhi 35b ND 53 ND
CD25 CD62Llo  175    10 (69.7)a ND 308   27 (67.5) ND
FoxP3 CD25 CD62Llo 37b ND 49 ND
aPercentage of CD4 CD25  T cells. Data are an average of five experiments (female) or two experiments (male).
bEstimated number based on average absolute number and average percent of FoxP3 .JEM VOL. 201, April 18, 2005 1337
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29, 30). In contrast, the majority of PLN CD62Lhi T cells
(70   5%) that were prepared from 4-wk-old NOD female
mice expressed an average of 105 copies of FoxP3 mRNA
per cell (Fig. 4, A and B). Strikingly, a marked decrease in
FoxP3-expressing CD62Lhi T cells was observed in the
PLNs of 8-wk-old NOD female mice (48.8   6.3%; P  
0.04; Fig. 4 A). Furthermore, a progressive decrease in the
percentage of FoxP3-expressing CD62Lhi T cells was de-
tected at later stages of   cell autoimmunity. In the PLNs of
16-wk-old and diabetic NOD female mice, only 28.8   3.8%
and 25   5% of CD62Lhi T cells, respectively, expressed
FoxP3 (Fig. 4 A). Despite a progressive loss of CD62Lhi T
cells that expressed the transcription factor, mRNA copy
number did not vary significantly among FoxP3-positive T
cells that were prepared from the respective groups of NOD
female mice (Fig. 4 B).
A significant percentage of CD62Llo T cells also was found
to express FoxP3 at comparable levels to CD62Lhi T cells (Fig.
Figure 4. The frequency of FoxP3-expressing CD62Lhi T cells decline 
with age in the PLNs of NOD but not NOR or B6 mice. Single T cells 
from the respective subsets were sorted from the PLNs of female NOD 
(A, B), NOR (C, D), and B6 (E, F) mice varying in age, and FoxP3 transcript 
copy number measured via RT-real time PCR. (A, C, E) Percentage of T cells 
expressing FoxP3. Data are an average of two separate experiments (40 cells/
experiment). *P   0.04, 4 wk versus 8 wk; #P   0.01, 8 wk versus 16 wk 
(Student’s t test). (B, D, F) FoxP3 transcript copy number for each individual 
T cell. Black bars represent the average transcript copy number per indi-
cated T cell subset. The number of FoxP3  T cells within the total number of 
T cells (80 cells) that were analyzed is provided above each column. Data 
are a compilation of two separate experiments (40 cells/experiment).THE ROLE OF CD4 CD25  T REG CELLS IN AUTOIMMUNE DIABETES | Pop et al. 1338
4, A and B). Within the CD62Llo pool, the highest percent of
FoxP3-expressing T cells was observed in PLNs of 4-wk-old
NOD female mice (35.0   1.0%); this decreased with age
(Fig. 4 A). In 8-wk-old NOD female mice for example, 22.5  
5.0% of CD62Llo T cells expressed FoxP3 (Fig. 4 A).
To determine whether the age-dependent decrease in
FoxP3-expressing T cells was unique to NOD mice, CD4 
T cells were prepared from the PLNs of B6 and NOR fe-
male mice that varied in age, and were analyzed as above.
The NOR mouse is a NOD-related MHC syngeneic re-
combinant strain that contains  12% C57BL/KsJ-derived
genes, exhibits peri-insulitis and only minimal intrainsulitis,
and fails to develop overt diabetes (31). Approximately 40%
and 20% of CD62Lhi and CD62Llo T cells, respectively, ex-
pressed FoxP3 independent of the age of the NOR or B6 fe-
male mice (Fig. 4, C and E). Furthermore, FoxP3 transcript
copy numbers that were expressed by PLN CD62Lhi T cells
were equivalent between NOR and B6 mice (Fig. 4, D and
F). At 16 wk of age, CD62Lhi T cells that were prepared
from NOD female mice expressed on average  10-fold less
FoxP3 transcripts relative to that detected in NOR and B6
mice (P   .0003; Fig. 4, B, D, and F). These data demon-
strate that despite an expanding number of PLN CD62Lhi
(and CD62Llo) T cells, the percentage of FoxP3-expressing
T cells declines as   cell autoimmunity progresses in NOD
female mice. In contrast, a temporal decrease in the percent-
age of FoxP3-expressing CD62Lhi (and CD62Llo) T cells was
not detected in NOR and B6 mice (Fig. 4, C and E, and
Table S1, available at http://www.jem.org/cgi/content/
full/jem.20042398/DC1). Importantly, the percentage of
FoxP3-expressing cells in NOD female mice at 16 wk of
age, when destructive insulitis has begun, was significantly
lower than in NOR and B6 mice (Fig. 4, A, C, and E;
Table I; and Table S1). Although the actual number of
FoxP3 CD62Lhi T cells in NOD female mice remained
constant (Table I), the suppressive capacity of this population
diminished with age (Fig. 1). Together, these data indicate
that an optimal ratio of CD4 CD25  T reg cells/effector T
cells is needed to suppress disease progression.
The percentage of TGF 1- and FoxP3-coexpressing PLN 
CD62Lhi T cells decreases as   cell autoimmunity progresses
Studies have shown that TGF 1 and IL-10 are key cyto-
kines that are expressed by CD4 CD25  T reg cells (32–34).
Analysis of transcript copy number demonstrated that none
of the FoxP3-positive CD62Lhi (or CD62Llo) T cells ex-
pressed detectable levels of IL-10 mRNA (data not shown).
Conversely,   80% of FoxP3-expressing CD62Lhi T cells
expressed TGF 1, regardless of the age of the NOD female
mice (Fig. 5 A). In addition, TGF 1 expression was detected
in  7% of FoxP3-negative CD62Lhi (or CD62Llo) T cells
(Table S2, available at http://www.jem.org/cgi/content/
full/jem.20042398/DC1). TGF 1 transcript copy number
varied with age (Fig. 5 A). For example, in 4- and 8-wk-old
NOD female mice, FoxP3-positive CD62Lhi T cells were
Figure 5. The frequency of TGF 1-expressing FoxP3  CD62Lhi 
T cells declines with age in the PLNs of NOD but not NOR or B6 
mice. TGF 1 transcript copy number was measured in single FoxP3  
T cells that were identified in Fig. 4. NOD (A), NOR (B), and B6 (C) female 
mice. Black bars represent the average copy number per indicated T cell 
subset. The number of TGF 1  T cells within the total number of 
FoxP3  T cells that were analyzed for a given subset is provided above 
each column. Data are a compilation of two separate experiments (40 
cells/experiment).JEM VOL. 201, April 18, 2005 1339
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defined by two distinct subsets based on high (1.2 to 1.3  
106) versus low (2.1 to 4.9   103) TGF 1 transcript copy
number per T cell. However, in 16-wk-old or diabetic ani-
mals, high copy TGF 1-expressing CD62Lhi T cells no
longer were detected (Fig. 5 A). In comparison, TGF 1
transcript copy number was relatively consistent in FoxP3-
expressing CD62Lhi T cells that were prepared from differ-
ent aged NOR and B6 female mice (Fig. 5, B and C). At 16
wk of age, FoxP3-positive CD62Lhi T cells that were pre-
pared from NOD female mice expressed on average 10- and
100-fold fewer TGF 1 transcripts compared with NOR and
B6 mice, respectively (P   0.009; Fig. 5).
Analogous to CD62Lhi T cells, TGF  was detected in
 80% of FoxP3-expressing CD62Llo T cells that were pre-
pared from PLNs of NOD, NOR, and B6 female mice, re-
gardless of age (Fig. 5). Furthermore, transcript copy number
varied only minimally among the respective groups within a
given mouse strain, and between NOD, NOR, and B6 mice
(Fig. 5). TGF 1 mRNA was detected in  4% of CD62Llo
T cells which lacked FoxP3 expression (Table S2). To-
gether, these results indicate that the percentage of TGF 1-
expressing CD62Lhi (and CD62Llo) T cells, and the level
of TGF 1 expression decreases in NOD female mice as  
cell autoimmunity progresses. Furthermore, the majority of
FoxP3-positive CD4 CD25  T reg cells coexpress TGF 1,
but not IL-10.
A temporal decrease in FoxP3- and TGF 1-coexpressing 
CD62Lhi T cells is not detected in NOD male mice
Differences in the extent of pancreatic inflammation be-
tween NOD versus NOR or B6 female mice may have
distinct effects on the activation and/or expansion of
CD4 CD25  T reg cells, which, in turn, may explain the
profiles of FoxP3- and TGF 1-coexpressing CD62Lhi (and
CD62Llo) T cells that are seen in the respective mice. To
rule out this possibility and determine whether decreasing
FoxP3- and TGF 1-coexpressing CD62Lhi in NOD female
mice is a consequence or cause of disease progression, NOD
male mice were studied. NOD male and female mice exhibit
similar insulitis with age, despite the fact that male animals
develop diabetes at a markedly reduced frequency. A similar
Figure 6. The frequency of TGF 1- and FoxP3-coexpressing 
CD62Lhi T cells remains constant with age in NOD male mice. 
(A and B) Sorted PLN T cells of the respective subsets from NOD male mice 
were examined for FoxP3 and TGF 1 transcript copy number. (A) Percent-
age of T cells expressing FoxP3. (B) FoxP3 transcript copy number per indi-
vidual T cell. (C) TGF 1 transcript copy number measured in single FoxP3  
T cells identified in (A). The number of TGF 1  T cells within the total 
number of FoxP3  T cells that were analyzed for a given subset is provided 
above each column. (A–C) Data are a compilation of two separate experi-
ments (40 cells/experiment). Black bars represent the average copy num-
ber per cell for the indicated T cell subset. (D) Sorted CD62Lhi T cells from 
the PLNs of female and male NOD mice at different ages were assessed at 
the indicated numbers to suppress proliferation of CD4 CD25- T cells as 
described in Fig. legend 1. Data are an average of two experiments per-
formed in triplicate. Standard deviation of any given data point   14%. 
[3H]thymidine uptake of CD4 CD25  T cells alone is 95420   996 cpm. 
*P   0.02, 16-wk NOD male vs. 16-wk NOD female (Student’s t test).THE ROLE OF CD4 CD25  T REG CELLS IN AUTOIMMUNE DIABETES | Pop et al. 1340
increase in the absolute number of PLN CD62Lhi and
CD62Llo T cells was detected in 4- and 16-wk-old NOD
male and female mice (Table I). However, the percentage of
PLN CD62Lhi (and CD62Llo) FoxP3-expressing T cells in
NOD male mice remained relatively constant with age (Fig.
6, A and B); this resembles the profiles that were seen in
NOR and B6 mice (Fig. 4, C–F). Furthermore,  80% of
FoxP3-expressing CD62Lhi (and CD62Llo) T cells in NOD
male mice expressed TGF 1, regardless of age (Fig. 6 C).
Moreover, in contrast to NOD female mice (Fig. 5 A),
TGF 1 transcript copy number in NOD male mice also re-
mained constant (Fig. 6 C). TGF 1 transcript copy number
was increased  10-fold more in PLN CD62Lhi (or CD62Llo)
FoxP3  T cells from male versus female NOD mice at 16
wk of age (Fig. 5 A and Fig. 6 C).
Next, the in vitro suppressor function of PLN CD62Lhi
T cells from NOD male mice was tested. PLN CD62Lhi T
cells from 4- and 16-wk-old NOD male mice suppressed
CD4 CD25  T cell proliferation similarly—and with signif-
icantly greater efficacy—to CD62Lhi T cells from 16-wk-old
female mice (P   0.001; Fig. 6 D). These results demon-
strate that unlike NOD female mice, the percentage of
FoxP3- and TGF 1-coexpressing CD62Lhi T cells—and as-
sociated TGF 1transcript copy number and suppressor func-
tion—remain constant with age.
Suppression mediated by PLN CD4 CD25  T reg cells 
is TGF  dependent
The above findings suggested that a progressive decline in
the percentage of TGF 1-expressing PLN CD4 CD25  T
reg cells promoted disease progression in NOD female mice.
To determine a role in CD4 CD25  T reg cell–mediated
suppression, the level of TGF  secretion in an in vitro
suppression assay was investigated. As the number of
CD4 CD25  T cells was decreased, significantly reduced
amounts of TGF  were detected in cultures that were estab-
lished from 16-wk-old versus 4- and 8-wk-old NOD female
mice (P   0.02; Fig. 7 A). Similarly, a marked reduction in
TGF  secretion was detected between CD4 CD25  T cells
that were isolated from the PLNs of 16-wk-old NOD versus
NOR and B6 female mice (Fig. 7 B). The declining levels of
TGF  reflected the reduced efficacy of the CD4 CD25  T
cells that were prepared from 16-wk-old NOD female mice
to suppress the proliferation of CD4 CD25  T cells (Figs. 1
A and 2 A).
To address whether decreased suppressor activity largely
was due to reduced TGF  production, the function of
CD62Lhi T cells that were prepared from 16-wk-old NOD
female mice was examined in an in vitro suppression assay
that was supplemented with recombinant human (rh)TGF .
Here, 3   103 CD62Lhi T cells and 105 CD4 CD25  T cells
were cultured with or without 425 pg of rhTGF . The
amount of rhTGF  was based on detected levels of TGF 
secretion by CD4 CD25  T cells (2.5   105) from 4-wk-
old NOD female mice mediating maximum suppression
Figure 7. Suppression mediated by CD4 CD25  T reg cells is TGF  
dependent. (A and B) Supernatants from suppression assays that were 
described in Fig. 1 were harvested and TGF  was detected via ELISA. Data 
is an average of two experiments performed in triplicate. Standard deviation 
of any given data point   31 pg/ml (A) or   52 pg/ml (B). *P   0.02, 
16 wk versus 4 or 8 wk; #P   0.02, 16 wk versus 4 wk or 8 wk. (C) Sorted 
CD62Lhi from the PLNs of NOD female mice 4 wk and 16 wk of age (3   
103) were coincubated with 105 CD4 CD25  T cells from 8-wk-old NOD 
female mice with or without 425 pg of rhTGF . Data are an average of 
two experiments performed in triplicate. Standard deviation of any given 
data point   17%. [3H]thymidine uptake of CD4 CD25  T cells alone is 
91457   721 cpm.  P   0.02, 16 wk plus rhTGF  versus 16 wk minus
rhTGF  (Student’s t test). (D) 2.5   104 sorted PLN CD4 CD25  T cells 
from 4-wk-old NOD female, NOD male, and B6 mice were coincubated 
with 105 CD4 CD25  T cells from 8-wk-old NOD and B6 female mice in 
the presence or absence of anti-TGF 1,2,3 or isotype control. Data is an 
average of two experiments performed in triplicate.JEM VOL. 201, April 18, 2005 1341
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(Fig. 7 A). When rhTGF  was added, CD62Lhi T cells from
16-wk-old NOD female mice suppressed proliferation of
CD4 CD25  T cells similarly to 4-wk-old CD62Lhi T cells
that had not been supplemented with cytokine (Fig. 7 C).
CD4 CD25  T cells alone did not produce TGF  upon ac-
tivation (Fig. 7 A), nor was FoxP3 expression induced in
CD4 CD25  T cells that were incubated with 425 pg of
rhTGF . For instance, no difference was detected in the fre-
quency ( 7.0%) of FoxP3-positive CD4 CD25  T cells
that were cultured with or without rhTGF . Furthermore,
when 5   104 CD62Lhi or CD62Llo T cells that were pre-
pared from PLNs of 4-wk-old NOD female mice were stim-
ulated individually in vitro, 345   48 pg/ml and 125   25
pg/ml of TGF  was detected, respectively. These data dem-
onstrate that the addition of TGF  can enhance the suppres-
sor function of CD62Lhi T cells from 16-wk-old NOD fe-
male mice, and that the source of TGF  that was detected in
in vitro suppression assays are CD62Lhi and CD62Llo T cells.
Finally, the addition of anti-TGF  Ab, but not an isotype
control Ab, effectively blocked—in a dose-dependent man-
ner—the capacity of CD4 CD25  T cells from female and
male NOD and B6 mice to mediate suppression (Fig. 7 D).
Together, these data demonstrate that TGF  produced by
the CD62Lhi (and CD62Llo) plays a key role in the observed
suppression; diminishing TGF  protein expression within
the pool of PLN CD4 CD25  T reg cells contributes to re-
duced effector function in an age-dependent manner.
Pancreatic islets and popliteal lymph nodes of NOD female 
mice exhibit a progressive loss of FoxP3- and TGF 1-
coexpressing CD62Lhi T cells
Islets also provide a key site for immunoregulation of   cell
specific T cell reactivity (32). Accordingly, CD4 CD25  T
reg cells that infiltrate the islets of 8- and 16-wk-old NOD
female mice were examined. As demonstrated in Table II, a
decrease in the number of CD62Lhi T cells (162   5 versus
111   3; P   0.04) and a concomitant increase in the num-
ber of CD62Llo T cells (320   3 versus 731   11; P   0.02)
that infiltrated the islets of 8- and 16-wk-old NOD female
mice, respectively, were detected. Similar to PLN (Fig.
4 A), a twofold reduction in FoxP3-positive CD62Lhi (and
CD62Llo) T cells was observed in the islet infiltrates of 8-
versus 16-wk-old NOD female mice (P   0.01; Fig. 8 A).
Again, as seen in PLN, two distinct subsets of FoxP3-
expressing CD62Lhi T cells, based on TGF 1 transcript
copy number, were detected in the islets of 8-wk-old, but
Figure 8. Diminishing frequencies of FoxP3- and TGF 1-coexpressing 
CD62Lhi T cells detected in the islet infiltrates and popliteal lymph 
nodes of NOD female mice. (A and B) FoxP3 and TGF 1 transcript copy 
number was determined in sorted, single T cells from islet infiltrates of 
8- and 16-wk-old NOD female mice. (A) Percentage of T cells expressing 
FoxP3. Data are an average of two separate experiments (40 cells/experiment). 
*P   0.01, 8 wk versus 16 wk; #P   0.01, 8 wk versus 16 wk. (B) TGF 1 
transcript copy number of FoxP3-expressing T cells. Black bars represent 
the average copy number per the indicated subset. The number of TGF 1  
T cells within the total number of FoxP3  T cells that were analyzed for a 
given subset is provided above each column. (C, D) FoxP3 transcript copy 
number was determined in sorted, single T cells from popliteal lymph 
nodes of 4- and 16-wk-old NOD (C) and B6 (D) female mice. Data are an 
average of two separate experiments (40 cells/experiment) ^P   0.02, 4 wk 
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not 16-wk-old, NOD female mice (Fig. 8 B). Furthermore,
none of the FoxP3-positive T cells expressed IL-10 only, al-
though  10% of FoxP3- and TGF 1-coexpressing T cells
were positive for IL-10 mRNA, independent of age (data
not shown). These findings demonstrate that analogous to
the PLN, the percentage of islet-infiltrating CD62Lhi (and
CD62Llo) T cells that coexpress FoxP3 and TGF 1 declines
as   cell autoimmunity progresses in NOD female mice.
To determine if the observed temporal decrease in the
percentage of FoxP3-expressing T cells was unique to sites
of inflammation, such as the PLN and islets, the popliteal
lymph nodes from 4- and 16-wk-old NOD female mice
were analyzed; B6 mice served as a control. A significant de-
crease in the percentage of CD62Lhi T cells that expressed
FoxP3 was detected in NOD, but not B6, female mice (Fig.
8, C and D). Transcript copy number of FoxP3 did not vary
and was similar to levels detected in PLN and islet-infiltrat-
ing CD62Lhi (and CD62Llo) T cells (Fig. S1 A, available at
http://www.jem.org/cgi/content/full/jem.20042398/DC1).
As above,  82% of FoxP3-positive T cells also expressed
TGF 1, independent of age. These data indicate that the
temporal decrease in the percentage of FoxP3- and TGF 1-
coexpressing T cells in NOD female mice is not due to acti-
vation and subsequent down-regulation of expression of
these genes, but rather is an intrinsic defect in the mainte-
nance of this T cell population.
DISCUSSION
The interplay between natural CD4 CD25  T reg cells and
pathogenic T cells in autoimmunity, including T1D, is
poorly understood. In part, this is due to the difficulty of ac-
curately distinguishing between CD4 CD25  T reg cells
and other subsets of immunoregulatory or pathogenic T ef-
fectors. In this study and others, natural CD4 CD25  T reg
cells have been defined based on a CD62Lhi surface pheno-
type, and expression of markers, such as CTLA-4, GITR,
CD45RB, CD103 (20, 29, 30), and more recently, lympho-
cyte activation gene-3 (33). Furthermore, various groups
have demonstrated that CD4 CD62Lhi T cells that were
prepared from the thymus or spleen of young NOD mice
block diabetes in adoptive transfer experiments (29, 30). De-
tection of FoxP3 mRNA also was used recently to define
CD4 CD25  T reg cells (21–23). However, bulk popula-
tions typically are studied so that the number/frequency of,
and the corresponding cytokines that are expressed by,
FoxP3-positive T cells cannot be determined readily. The
latter is of significance in view of the apparent heterogeneity
within CD4 CD25  T reg cells regarding expression and
the respective roles of TGF 1 and/or IL-10 in suppressor
activity (24–26). We have addressed these issues by using a
real-time PCR assay to measure FoxP3 and cytokine expres-
sion in single cells.
Two conclusions pertaining to the general properties of
CD4 CD25  T reg cells can be drawn based on the single
cell analyses that were made in NOD, NOR, and B6 mice.
First, only a subset ( 40%) of single CD62Lhi T cells express
significant levels of FoxP3. Furthermore, a considerable
number ( 20%) of CD62Llo T cells also express FoxP3; this
is consistent with work by the Salomon group (34) that
showed that proliferating CD4 CD25  T reg cells down-
regulate CD62L expression. The pool of CD62Llo T cells
exhibited a markedly reduced suppressor function relative to
CD62Lhi T cells (Fig. 2, A and B); this suggests that
CD4 CD25  T reg cells effector function is regulated
tightly. Together, however, these results further underscore
the difficulty of characterizing CD4 CD25  T reg cells
based on surface phenotype alone. Second, the majority
( 80%) of single, FoxP3-positive T cells express TGF 1 but
not IL-10. Noteworthy, however, is that a small percentage
( 10%) of FoxP3- and TGF 1-positive CD62Lhi T cells in
the islets, but not PLNs, of NOD mice also expressed IL-10
(data not shown). FoxP3-positive T cells that express IL-10,
but not TGF 1, normally may represent a minor population
of CD4 CD25  T reg cells that undergo expansion under
certain proinflammatory conditions (26). A role for TGF 1
was demonstrated by the capacity of neutralizing Ab to
block completely CD4 CD25  T reg cell–mediated sup-
pression in vitro (Fig. 7 D). The latter does not rule out cell–
cell contact as a means by which these CD4 CD25  T reg
cells mediate suppression in vivo. In fact, cell–cell contact is
likely to be the predominant mechanism of suppression of
the few FoxP3-positive T cells ( 20%) that lack TGF 1 ex-
pression (Fig. 5 and Table S2). Our observation that anti-
TGF  Ab blocked the in vitro suppressor activity of NOD
and B6 CD4 CD25  T reg cells (Fig. 7 D) is consistent
with findings that were reported by Nakamura et al; they
used the same polyclonal anti-TGF  Ab (1D11) to inhibit
the function of BALB/c CD4 CD25  T reg cells in vitro
(35). In addition, several studies demonstrated that the sup-
pressor activity of CD4 CD25  T reg cells upon adoptive
transfer is blocked in vivo by anti-TGF  Ab treatment (36,
Table II. Absolute number and percentage of CD4 , 
CD4 CD25 , CD25 CD62Lhi, and CD25 CD62Llo per 10,000 
lymphocytes within the islet infiltrate of NOD female mice
NOD female islet infiltrate
Average absolute number
8 wk 16 wk
(%) (%)
CD4  4,594   176 5,818    127
CD25  482   10 842   8
CD25 CD62Lhi 162   5 (33.6)a 111   3 (13.2)
FoxP3 CD25 CD62Lhi 59b 23
CD25 CD62Llo 320   3 (66.4)a 731   11 (86.8)
FoxP3 CD25 CD62Llo 108b 131
aPercentage of CD4 CD25  T cells. Data are an average of two experiments.
bEstimated number based on average absolute number and average percentage 
of FoxP3 .JEM VOL. 201, April 18, 2005 1343
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37). Nevertheless, under certain conditions, suppression of
CD4 CD25  T cells by CD4 CD25  T reg cells can be
mediated independent of TGF  (38); this suggests that the
role of this cytokine in CD4 CD25  T reg cell function is
complex. Shevach and colleagues suggested that TGF 1, in
an autocrine manner, may have a direct effect on the induc-
tion of CD4 CD25  T reg cell function (38). Reduced
TGF 1 expression (Fig. 5 A) correlated with a decreased
number of FoxP3-expressing CD4 CD25  T cells in older
NOD female mice (Fig. 4, A and B). Accordingly, lower
levels of autocrine TGF 1 may affect the maintenance/
expansion and the function of FoxP3-positive CD4 CD25 
T reg cells adversely in older NOD female mice.
Another key observation that was made in this study is
that the function and phenotype of CD4 CD25  T reg cells
in NOD female mice undergo marked changes in an age-
dependent fashion. For example, the in vitro and in vivo sup-
pressor function of PLN CD4 CD25  T cells declined sig-
nificantly from 4 to 8 and 16 wk of age (Fig. 1). The loss of
suppressor activity was detected, despite increasing numbers
of PLN CD62Lhi T cells. Therefore, the progressive loss of
suppressor activity by sorted CD62Lhi (and CD62Llo) T cells
(Fig. 2 A) indicated an intrinsic defect within this pool of im-
munoregulatory effectors. Consistent with this finding, real-
time PCR analysis demonstrated that the percentage of single
CD62Lhi T cells that coexpresses FoxP3 and TGF 1 declined
with age in the PLN (Fig. 4, A and B) and islets (Fig. 8 B).
CD62Lhi T cells that were sorted from 4-wk-old NOD mice
exhibited the most effective suppressor activity (Fig. 2 A),
which, in turn, correlated with the greatest number of
FoxP3- and TGF 1-coexpressing T cells (Fig. 4, A and B).
In comparison, the pool of CD62Lhi T cells from 8-wk-old
NOD female mice exhibited decreased suppressor activity
(Fig. 2 A). The latter was due to a reduced frequency of
FoxP3- and TGF 1-expressing CD62Lhi T cells in 8- versus
4-wk-old NOD female mice (Fig. 4 A). Notably, TGF 1
transcript copy number was equivalent between the FoxP3-
expressing CD62Lhi T cells of 4- and 8-wk-old NOD female
mice. In older NOD female mice, the suppressor function of
CD62Lhi T cells was reduced further (Fig. 2 A). However, in
this case, not only was the frequency of FoxP3- and TGF 1-
coexpressing CD62Lhi T cells reduced but so was the level of
TGF 1 expression by these T cells (Fig. 4, A and B; Fig. 5
A). It is likely that both factors contribute to the relatively in-
effective suppressor activity that is exhibited by this pool of
CD62Lhi T cells. Nevertheless, at high numbers (i.e., 5  
104), CD62Lhi T cells from 16-wk-old NOD female mice
exhibited in vitro suppressor activity that was equivalent to
that of 4- and 8-wk-old NOD female mice (Fig. 2 A).
This result indicates that at an optimal number/frequency,
CD62Lhi T cells exhibit effective immunoregulatory func-
tion, despite reduced TGF  production. These data further
demonstrate that the progressive loss of suppressor activity
within the pool of CD4 CD25  T reg cells in NOD female
mice is associated with multiple defects.
The temporal profile of FoxP3- and TGF 1-coexpress-
ing T cells differed markedly between NOD female mice
versus B6, NOR, and most notably, NOD male, mice (Figs.
4 and 6). Almost a twofold increase in FoxP3- and TGF 1-
positive CD62Lhi T cells was detected in 4-wk-old NOD fe-
male mice relative to B6, NOR, and NOD male mice of the
same age. This was despite the fact that in 4-wk-old NOR
and B6 mice, the number of PLN CD62Lhi T cells was ap-
proximately two- to threefold greater than that observed in
NOD female mice (Table S1). However, the progressive loss
of FoxP3- and TGF 1-coexpressing cells within the pool of
CD62Lhi (and CD62Llo) T cells was detected only in NOD
female mice. In B6, NOR, and NOD male mice, equivalent
numbers of FoxP3- and TGF 1-positive T cells remained
constant with age (Fig. 4, C–F, and Fig. 6, A and B). The
fact that infiltration of the PLNs and islets is similar between
NOD male and female mice (Table I) suggests that ongoing
inflammation does not account for down-regulation of
FoxP3 (and TGF 1) expression as a result of the activational
and/or proliferative status of CD4 CD25  T reg cells. A
similar decline in the frequency of FoxP3- and TGF 1-
coexpressing CD62Lhi and CD62Llo T cells was detected in
the popliteal lymph nodes of NOD female mice (Fig. 8 C), a
site that lacks obvious inflammation. These data strengthen
the hypothesis that the progressive loss of FoxP3- and
TGF 1-coexpressing CD4 CD25  T reg cells in NOD fe-
male mice directly contributes to the development of aggres-
sive insulitis and overt diabetes.
The events that influence the frequency of FoxP3- and
TGF 1-coexpressing CD4 CD25  T reg cells in NOD
mice is not clear, although a number of mutually nonexclu-
sive possibilities exist. Thymic selection may become limit-
ing for CD4 CD25  T reg cells in NOD mice, thereby in-
directly affecting the size of the peripheral pool. Various
groups, for instance, have documented aberrant thymocyte
selection (3, 4) and abnormal thymic physiology (39) in the
NOD mouse. Treatment of neonatal NOD mice with anti-
TNF  Ab increases the number of thymic CD4 CD25  T
cells (40). Second, a defect in maintenance and/or expansion
of FoxP3- and TGF 1-coexpressing CD4 CD25  T reg
cells may contribute to the decline of these immunoregula-
tory effectors. Various molecules, including CTLA-4, TNF-
related activation-induced cytokine, GITR, and lymphocyte
activation gene-3, are potential candidates which affect the
induction and/or expansion of CD4 CD25  T reg cells (20,
33, 41–43). The temporal decline in TGF 1 mRNA that
was detected in FoxP3-expressing CD4 CD25 CD62Lhi T
cells (Fig. 5), and the corresponding decrease in TGF  se-
cretion (Fig. 7), may hinder the expansion and/or mainte-
nance of CD4 CD25  T reg cells during inflammation. Re-
cent work by the Flavell group demonstrated that ectopic
expression of TGF 1 by   cells increased the frequency of
FoxP3-expressing CD4 CD25  T reg cells, and protected
the transgenic NOD mice from diabetes (44). Finally, it has
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sion by CD4 CD25  T cells may contribute to the mainte-
nance and/or expansion of the CD4 CD25  T reg cells.
The intrinsic properties of CD4 CD25  T cells or the lack
of appropriate signals in NOD mice may limit the efficiency
of such a mechanism. For instance, TGF 1 was shown to
induce FoxP3 expression in CD4 CD25  T cells in vitro
(45, 46). Once again, limiting amounts of TGF  that is pro-
duced by NOD CD4 CD25  T reg cells would be ex-
pected to reduce the efficiency of such a mechanism.
This study and others highlight the complexity among
immunoregulatory T cells that modulate the progression
of T1D. Adorini and colleagues demonstrated that CD4 
CD25  T cells that were prepared from the spleen of NOD
mice also exhibited varying suppressor activity in an age-
dependent manner (7). In contrast to the findings herein,
immunoregulatory CD4 CD25  T cells were characterized
by expression of IL-10, although in vitro suppression was
mediated in an IL-10–independent manner. Expression of
FoxP3 or TGF 1 was not assessed in this pool of CD4 
CD25  T cells. Recent work by Benoist et al. showed that
progression of insulitis in BDC2.5 mice was dependent on
FoxP3-expressing CD4 CD25 CD69  T cells which reside
within the islets (32). This population of immunoregulatory
T effectors also was characterized by expression of IL-10; in
vivo persistence was dependent on inducible costimulatory
expression. Sufficient expansion of this subset of CD4 
CD25  T reg cells may have been facilitated by expression
of the BDC2.5 clonotypic TCR in this model.
In summary, we propose that a progressive decline in
the percentage of FoxP3- and TGF 1-coexpressing
CD4 CD25  T reg cells contributes to the development of
“aggressive” insulitis in NOD female mice. During the pre-
diabetic stage, a balance between pathogenic T cells and
CD4 CD25  T reg cells that reside in the PLNs and islets is
maintained. However, as FoxP3- and TGF 1-positive–
expressing T cells decline within the pool of CD4 CD25 
T reg cells, a minimum threshold is surpassed and pathogenic
  cell–specific T effectors are permitted to expand (Table I)
and drive the response to an overt diabetic state. However,
in NOD male mice, the pool of FoxP3- and TGF 1-coex-
pressing CD4 CD25  T reg cells is relatively stable; this is
reflected by a markedly reduced frequency of diabetes
( 20%) compared with NOD female mice ( 80%). Defin-
ing the mechanism that determines the frequencies of
FoxP3- and TGF 1-coexpressing CD4 CD25  T reg cells
is likely to provide key insight into events that regulate T1D
and other tissue-specific autoimmune diseases.
MATERIAL AND METHODS
Mice. NOD/LtJ, NOR/LtJ, NOD.BDC2.5, C57BL/6 (B6), and
NOD.scid mice were housed under specific pathogen-free conditions. Dia-
betes develops in  80% and  20% of NOD female and male mice, respec-
tively, by 1 yr of age. Mice were maintained in an American Association of
Laboratory Animal Care-accredited facility, and studies were approved by
the Institutional Animal Care and Use Committee of the University of
North Carolina at Chapel Hill.
Flow cytometric analysis. Abs were purchased from BD Biosciences and
used for analysis of CD4 CD25  T cells: FITC-labeled rat anti–CD3
(17A2), PerCP-labeled rat anti–CD4 (GK1.5), APC-labeled rat anti–CD25
(PC61), PE-labeled rat anti–CD62L (Mel-14), PE-labeled anti–CD103
(M290), PE-labeled anti–CTLA-4 (UC10-4F10-11), biotinylated rat anti–
CD69 (H1.2F3), and biotinylated anti–CD45RB (16A). Purified rat anti–
mouse GITR (108619) was purchased from R&D Systems. CD4 CD25 
and CD4 CD25  T cells were sorted using a MoFlo high-speed sorter (Da-
koCytomation) for single cell real-time PCR analysis, suppression assays, and
adoptive transfer experiments. Sorted bulk populations,  98% purity, were
stained with the aforementioned Abs. T cell preparations were stained in 5%
FBS/PBS for 30 min on ice. When necessary, T cells also were incubated
with secondary antibodies, PE-labeled streptavidin (BD Biosciences) or PE-
labeled anti–rat IgG (Southern Biotechnology Associates Inc.) for 30 min on
ice and washed. Flow cytometry data were acquired at the University of
North Carolina Flow Cytometry and evaluated by Facility using a FACS
Calibur (Becton Dickinson) and Summit software (DakoCytomation).
Single cell real-time PCR. Single CD4 CD25 CD62Llo, CD4 CD25 
CD62Lhi, or CD4 CD25  T cells were sorted into individual wells of a 96-
well polypropylene RNase/DNase-free plate (USA Scientific) which con-
tained 4  l of cell lysis buffer and stored at  80 C. cDNA was synthesized
using SuperScript II (Invitrogen), oligo(dT) primers (Invitrogen), RNase Out
(Invitrogen), and thermocycler (GeneAmp 9700, Applied Biosystems) condi-
tions that consisted of 40 C for 40 min and 70 C for 15 min. Real-time PCR
primers and probes that are specific for FoxP3 (5 -CCCAGGAAAGACAG-
CAACCTT-3 ; 5 -TTCTCACAACCAGGCCACTTG-3 ; 5 -fam/ATC-
CTACCCACTGCTGGCAAATGGAGTC/tam-3 ), TGF 1 (5 -CACT-
GATACGCCTGAGTG-3 ; 5 -GTGAGCGCTGAATCGAAA-3 ; 5 -fam/
CCGTCTCCTTGGTTCAGCCACTG/tam-3 ), and IL-10 (5 -CAGA-
GCCACATGCTCCTA-3 ; 5 -GGAGTCGGTTAGCAGTATG-3 ; 5 -
fam/CTGCGGACTGCCTTCAGCCAG/tam-3 ) were synthesized by In-
tegrated DNA Technologies. A standard curve that was generated from serial
dilutions of purified plasmid DNA that encoded the respective genes was
used to measure mRNA transcript copy number. The lower limit of detec-
tion was 10 copies for all genes tested. Each gene was detected in indepen-
dent real-time PCR reactions using 5  l of a 25- l total cDNA mixture.
Copy number of mRNA encoding  -actin was analyzed in the same sample
using 5 -AGAGGGAAATCGTGCGTGAC-3 ; 5 -CAATAGTGATGAC-
CTGGCCGT-3 ; 5 -fam/CACTGCCGCATCCTCTTCCTCCC/tam-3 
by Integrated DNA Technologies. Data are expressed as a copy number nor-
malized to  -actin content. The normalized mRNA copy number for a gene
was determined by: [raw transcript copy number derived from standard
curve]   [ -actin corrective ratio]. The  -actin corrective ratio was calcu-
lated as [lowest  -actin copy number within sample set]/[ -actin copy num-
ber for cell of interest].
In vitro CD4 CD25  T cell suppression assay. CD4 CD25  T cells
that were sorted from PLNs were cocultured in 96-well plates with 105
CD4 CD25  T cells that were sorted from PLNs plus 1  g/ml of
anti-CD3  (145-2C11; eBioscience) and 105 irradiated T cell depleted
splenocytes. Splenocytes were depleted of T cells by incubation with anti-
Thy1.1–coated magnetic microbeads (Miltenyi Biotec) and then magnetic-
activated cell separation was selected according to the manufacturer’s proto-
col. T cells were cultured in RPMI 1640 which was supplemented with
10% FBS, 50  M 2-ME, 1  nonessential amino acids, 1 mM sodium pyru-
vate, 2 mM L-glutamine, 100 U/ml penicillin, and 100  g/ml streptomy-
cin for 72 h at 37 C, and then pulsed with 1  Ci/well of [3H]thymidine for
18 h. [3H]thymidine incorporation was measured by a scintillation counter
(Beckman LS6500). Percent inhibition was determined by the following
equation: 1   {[(CD4 CD25     CD4 CD25 ) cpm]/[(CD4 CD25 
alone) cpm]}   100. Some studies included the addition of anti-TGF 1,2,3
(1D11) or IgG1 isotype control Ab (R&D Systems) at 10 or 100  g/ml, or
425 pg of rhTGF  (BD Biosciences).JEM VOL. 201, April 18, 2005 1345
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Measurement of IL-10 and TGF  secretion via ELISA. A capture
ELISA was used to measure levels of IL-10 and TGF  in supernatants that
were harvested from individual wells that were prepared for the in vitro
suppression assay that was described above. In brief, 96-well plates were
coated with 2  g/ml of rat anti–TGF  or rat anti–IL-10 (BD Biosciences)
prepared in carbonate buffer pH 9.0 and incubated overnight at 4 C. Plates
were blocked, and 50  l of culture supernatant (diluted 1:2) was added per
well and incubated overnight at 4 C. Plates were washed (1% BSA/.05%
Tween 20/PBS) and incubated for 2 h at room temperature with 1  g/ml
of biotinylated rat anti–TGF  or rat anti–IL-10 (BD Biosciences). Plates
were washed, and streptavidin-alkaline phosphatase (BD Biosciences) was
added at a 1/1000 dilution and incubated for 2 h. After washing, plates were
developed using 200  l of diethenolamine buffer with p-N-PP substrate
(Sigma-Aldrich). Cytokine concentrations in culture supernatants were de-
termined using standard curves of hTGF  and mIL-10 (BD Biosciences).
The lower limit of detection for IL-10 and TGF  was 40 pg/ml.
In vivo CD4 CD25  T cell suppression assay. 5   105 CD4 CD25 
T cells that were sorted from the PLNs ( 90% purity) of NOD female
mice were coinjected i.v. with 5   106 splenic BDC2.5 CD4  T cells into
NOD.scid recipients. Splenic BDC2.5 CD4  T cells were isolated with
anti-CD4–coated magnetic microbeads (Miltenyi Biotec) followed by
MACS selection. Mice were monitored daily for the development of glyco-
suria with diastix (Bayer Corporation).
Pancreatic islet isolation. Pancreases from groups of eight or nine mice
were perfused with 2 mg/ml collagenase P (Roche) and digested for 20 min
at 37 C. Islets were purified via Ficoll gradient, handpicked, and then disso-
ciated into a single cell suspension using enzyme-free cell dissociation solu-
tion (Sigma-Aldrich). Cells were washed and prepared for flow cytometric
analysis of CD4 CD25  T cells.
Online supplemental material. Fig. S1 provides data for FoxP3 expres-
sion in CD62Lhi and CD62Llo sorted T cells prepared from the popliteal
lymph nodes of NOD and B6 female mice. Table S1 provides the absolute
number and percentage of FoxP3  and FoxP3  CD4 CD25  T cells ex-
pressing TGF 1 prepared from the PLNs of NOD, NOR, and B6 female
mice varying in age. Table S2 provides the absolute number of CD4 ,
CD4 CD25 , CD62Lhi, and CD62Llo T cells prepared from the PLNs of
NOR and B6 female mice varying in age. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20042398/DC1.
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